Braskem S.A.BAKNYSE
Loading
R&D Expense Growth TrendStable
Percentile Rank51
3Y CAGR-28.8%
5Y CAGR-6.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-28.8%/yr
vs +68.0%/yr prior
5Y CAGR
-6.3%/yr
Recent deceleration
Acceleration
-96.8pp
Decelerating
Percentile
P51
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q3 2025 | 12.04% |
| Q2 2025 | -14.29% |
| Q1 2025 | -11.89% |
| Q4 2024 | 31.19% |
| Q3 2024 | 2.83% |
| Q2 2024 | 0.00% |
| Q1 2024 | -8.62% |
| Q4 2023 | 26.09% |
| Q3 2023 | 13.58% |
| Q2 2023 | 349.10% |
| Q1 2023 | -84.84% |
| Q4 2022 | 14.42% |
| Q3 2022 | 33.33% |
| Q2 2022 | 6.97% |
| Q1 2022 | -26.04% |
| Q4 2021 | 33.63% |
| Q3 2021 | 18.91% |
| Q2 2021 | 0.07% |
| Q1 2021 | -20.51% |
| Q4 2020 | 23.81% |
| Q3 2020 | 16.67% |
| Q2 2020 | -2.70% |
| Q1 2020 | -29.03% |
| Q4 2019 | 33.32% |
| Q3 2019 | 12.80% |
| Q2 2019 | 6.17% |
| Q1 2019 | -19.71% |
| Q4 2018 | 14.93% |
| Q3 2018 | 13.53% |
| Q2 2018 | 20.10% |
| Q1 2018 | -31.07% |
| Q4 2017 | 45.40% |
| Q3 2017 | 0.93% |
| Q2 2017 | 14.32% |
| Q1 2017 | -19.85% |
| Q4 2016 | 12.85% |
| Q3 2016 | -7.03% |
| Q2 2016 | -6.01% |
| Q1 2016 | -14.40% |
| Q4 2015 | 31.93% |